Andrew Sheely
Direttore Tecnico/Scientifico/R&S presso VERVE THERAPEUTICS, INC.
Profilo
Andrew Sheely is currently the Vice President of Information Technology at Verve Therapeutics, Inc. Previously, he held positions as the Head of Information Technology at Dyax Corp., Kaleido Biosciences, Inc., and CRISPR Therapeutics, Inc. He completed his undergraduate degree at the University of Rhode Island and his graduate degree at Regis University.
Posizioni attive di Andrew Sheely
| Società | Posizione | Inizio |
|---|---|---|
| VERVE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Andrew Sheely
| Società | Posizione | Fine |
|---|---|---|
CRISPR Therapeutics, Inc.
 CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of CRISPR Therapeutics AG, CRISPR Therapeutics, Inc. develops gene-based medicines for the treatment of human diseases. The company is based in Cambridge, MA. The CEO of the company is Samarth Kulkarni. | Direttore Tecnico/Scientifico/R&S | - |
| DYAX CORP. | Direttore Tecnico/Scientifico/R&S | - |
| KALEIDO BIOSCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Andrew Sheely
| University of Rhode Island | Undergraduate Degree |
| Regis University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| VERVE THERAPEUTICS, INC. | Health Technology |
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of CRISPR Therapeutics AG, CRISPR Therapeutics, Inc. develops gene-based medicines for the treatment of human diseases. The company is based in Cambridge, MA. The CEO of the company is Samarth Kulkarni. | Health Technology |
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
- Borsa valori
- Insiders
- Andrew Sheely
